AstraZeneca PLC (AZN)
Last Price$63.2(2.8%)
Market Cap$270.4B
Financial profile score
3/10
LTM Revenue
$49.1B
+3.2% YoY
LTM Net Income
$6.4B
+1.7% YoY
LTM Free Cash Flow
$7.2B
+22.0% YoY
Net Debt
$26.6B
Short-term financial position
0.9x
Current Assets / Current Liabilities
AZN Income statement
Crunching data... Almost there!
AZN Balance sheet
Crunching data... Almost there!
AZN Key balance sheet metrics
Crunching data... Almost there!
AZN Cash flow statement
Crunching data... Almost there!
AZN Key cash flow statement metrics
Crunching data... Almost there!
Discover more AZN fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What are AstraZeneca PLC (AZN) Key Income Statement Metrics?
As of today, AstraZeneca PLC last 12-month Revenue is $49.1B , EBITDA is $14.9B and Net Income is $6.4B , based on the financial report for Jun 30, 2024 (Q2 2024).
What are AstraZeneca PLC (AZN) Key Balance Sheet Metrics?
As of today, AstraZeneca PLC Total Assets are $104.3B and Total Liabilities are $64.7B , based on the financial report for Jun 30, 2024 (Q2 2024).
What are AstraZeneca PLC (AZN) Key Cash Flow Statement Metrics?
As of today, AstraZeneca PLC last 12-month Cash Flow from Operating Activities is $3,198.0M, Cash Flow from Investing Activities is ($2,985.0M) and Cash Flow from Financing Activities is ($1,222.0M), based on the financial report for Jun 30, 2024 (Q2 2024).
What is AstraZeneca PLC (AZN) Free Cash Flow?
As of today, AstraZeneca PLC last 12-month Free Cash Flow is $7.2B , based on the financial report for Jun 30, 2024 (Q2 2024).